Diabetes

National Diabetes Month

Each November, AdvaMed partners with our member companies to raise awareness and highlight medtech’s role in helping patients manage their diabetes and live fuller and better lives.

Diabetes

Medtech’s Role in Improving Diabetes Care

November is National Diabetes Awareness Month, a time to shine a spotlight on one of the most prevalent and pressing health issues of our time: diabetes. This month serves as a critical reminder of the importance of understanding, preventing, and managing diabetes, which affects millions of Americans and their families. Through education, advocacy, and community support, Advamed, our member companies, and our partners aim to raise awareness about diabetes, its risk factors, and the steps individuals can take to live healthier, more fulfilling lives.

AdvaMed® Members and Partners Recognize National Diabetes Month

Diabetes Patient Stories

Patient

Married by Medtech: Natalie’s and James’ Story

Chronic illness hasn’t stopped Natalie and James from pursuing their fairytale, and medtech has ensured as smooth a pursuit as possible.

Patient

Living Fearlessly in the Face of Diabetes

Hannah’s journey with type one diabetes started when she was ten years old. Now she uses a continuous glucose monitoring system, which records blood sugar levels constantly.

Related Reading

News / Coverage & Payment / Diabetes / Government & Legislative Affairs / Health Access

AdvaMed Welcomes Bipartisan, Bicameral Congressional Diabetes Caucus Concerns Over Draft Medicare Competitive Bidding Proposal

November 3, 2025

WASHINGTON—AdvaMed, the world’s largest trade association representing medtech innovators, today welcomed a letter from U.S. Senators Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.), co-chairs of the Senate Diabetes Caucus, and U.S. Representatives Diana DeGette (D-Colo.-01) and Gus Bilirakis (R-Fla.-12), co-chairs of the U.S. House Diabetes Caucus, to Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz urging the agency not to finalize a proposal the lawmakers warned could reduce and complicate patient access to continuous glucose monitors (CGMs) and durable insulin pumps.

News / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access

AdvaMed Welcomes CMS’ Rural Health Transformation Program

September 15, 2025

WASHINGTON—AdvaMed, the medtech association, welcomed today’s CMS’ announcement of the details of the $50 billion Rural Health Transformation Program. This program gives states the chance to access the latest health care technologies that best suit their needs to improve health outcomes for rural Americans.

News / Coverage & Payment / Diabetes / Government & Legislative Affairs / Health Access

AdvaMed Urges CMS to Fix “Serious Flaws” in Proposed Medicare Durable Medical Equipment Competitive Bidding Rule, Cites Concerns of Patient Safety, Fewer Treatment Options, Increased Costs if Rule Stands 

August 28, 2025

WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medtech innovators, today urged the Centers for Medicare and Medicaid Services (CMS) to fix “serious flaws” in its proposed rule to restart competitive bidding for durable medical equipment in Medicare, citing risks to patient safety, fewer product choices for beneficiaries, and cost increases that would result if the rule stands. 
View All

Search